Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers? Afschin Gandjour Editorial 04 June 2016 Pages: 507 - 509
Supporting Medicare Health, Equity and Efficiency in Australia: Policies Undermining Bulk Billing Need to Be Scrapped Simon EckermannLynnaire Sheridan Commentary 20 July 2016 Pages: 511 - 514
The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Alistair RayHelen MorganGrace Carolan-Rees Review Article Open access 30 January 2016 Pages: 515 - 526
Health Economic Evaluations of Sofosbuvir for Treatment of Chronic Hepatitis C: a Systematic Review Miriam LuhnenSiw WaffenschmidtGloria Hanke Systematic Review 21 June 2016 Pages: 527 - 543
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK Stephen MontgomeryJeanette KuselNicholas Adlard Systematic Review 29 April 2016 Pages: 545 - 558
A Qualitative Evaluation of Program Budgeting and Marginal Analysis in a Canadian Pediatric Tertiary Care Institution Neale SmithCraig MittonShashi Ashok Gujar Original Research Article 11 June 2016 Pages: 559 - 568
Barrier to Access or Cost Share? Coinsurance and Dental-Care Utilization in Colombia Lucas HigueraSergio Iván Prada Original Research Article 22 June 2016 Pages: 569 - 578
Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal M. Reza Maleki-YazdiMathieu MolimardDavid Price Original Research Article 11 August 2016 Pages: 579 - 594
Care Appropriateness and Health Productivity Evolution: A Non-Parametric Analysis of the Italian Regional Health Systems Paolo MancusoVivian Grace Valdmanis Original Research Article 22 July 2016 Pages: 595 - 607
Cost of Purchased Versus Produced Plasma from Donor Recruitment Through Transfusion Katherine M. PrioliLaura T. PizziPlasma Cost Focus Group Original Research Article 08 July 2016 Pages: 609 - 617